Showing 1 - 20 results of 38 for search '"Neovascularization, Pathologic drug therapy"', query time: 1.60s Refine Results
1
Ectopic high endothelial venules in pancreatic ductal adenocarcinoma: A unique site for targeted delivery

Authors: Takaharu Ichimura, Vivek Kasinath, Farideh Ordikhani, Jonathan S. Bromberg, Leonard D. Shultz, Baharak Bahmani, Xiaofei Li, Liwei Jiang, Mayuko Uehara, Siawosh K. Eskandari, Naima Banouni, Reza Abdi, Dale L. Greiner, Nasim Annabi

Source: EBioMedicine
EBioMedicine, 38, 79-88. ELSEVIER SCIENCE BV

Subject Terms: General Biochemistry, Genetics and Molecular Biology, General Medicine, High endothelial venules, Apoptosis, Humanized mouse, Cancer, medicine.disease, medicine, Paclitaxel, chemistry.chemical_compound, chemistry, business.industry, business, Lymph, Addressin, biology.protein, biology, Cancer research, Monoclonal antibody, medicine.drug_class, Endothelium, Lymphatic, Lymph Nodes, Cell Line, Animals, Humans, Mice, Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms, Disease Models, Animal, Neovascularization, Pathologic, Antineoplastic Agents, Immunohistochemistry, Xenograft Model Antitumor Assays, Female, Male, Nanoparticles, Molecular Targeted Therapy, Biomarkers, Theranostic Nanomedicine, MECA79 coated nanoparticles, Pancreatic ductal adenocarcinoma, Peripheral node addressin, Taxol, Clinical Sciences, Public Health and Health Services, Research paper, Antineoplastic Agents/chemistry, Carcinoma, Pancreatic Ductal/drug therapy, Disease Models, Animal, Endothelium, Lymphatic/drug effects, Lymph Nodes/pathology, Nanoparticles/chemistry, Neovascularization, Pathologic/drug therapy, Paclitaxel/administration & dosage, Pancreatic Neoplasms/drug therapy, digestive system diseases, education, endocrine system diseases

File Description: application/pdf

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::044e87ff020243ebf878836146fb7676
https://api.elsevier.com/content/article/PII:S2352396418305346?httpAccept=text/xml

2
Targeting α1 inserted domain (I) of α1β1 integrin by Lebetin 2 from M. lebetina transmediterranea venom decreased tumorigenesis and angiogenesis

Authors: Najet Srairi Abid, Erij Messadi, Mohamed El Ayeb, Jed Jebali, José Luis, Houcemeddine Othman, Maram Morjen, Naziha Marrakchi, Zaineb Abdelkafi-Koubaa

Contributors: Laboratoire des Venins et Biomolécules Thérapeutiques - Laboratory of Venoms and Therapeutic Biomolecules (LR11IPT08), Institut Pasteur de Tunis, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP), Institut de neurophysiopathologie (INP), Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS), Faculté de Médecine de Tunis, Université de Tunis El Manar (UTM), This work was supported in part by MERST (Ministère de l'Enseignement Supérieur de la Recherche et de la Technologie) (Laboratoire des venins et biomolécules thérapeutiques: LR11IPT08), INSERM UMR911 (Institut National de la Santé et de la Recherche Médicale) and by grants ARCUS (Action en Région de Coopération Universitaire et Scientifique (2008–2012)) and PHC Utique (17G0811: 2017–2019)., We thank Pr Hechmi Louzir, head of Institut Pasteur de Tunis for his continuous interest in this study and for his support. Dr. Benlasfar Zakaria (Institut Pasteur de Tunis) is acknowledged for providing viper venom., Centre National de la Recherche Scientifique (CNRS)-Aix Marseille Université (AMU)

Source: International Journal of Biological Macromolecules
International Journal of Biological Macromolecules, Elsevier, 2018, 117, pp.790-799. ⟨10.1016/j.ijbiomac.2018.05.230⟩

Subject Terms: Adhesion, Angiogenesis, Integrin, Migration, Snake venom, MESH: Amino Acid Sequence, MESH: Angiogenesis Inhibitors/metabolism, MESH: Cricetulus, MESH: Integrin alpha1beta1/chemistry, MESH: Integrin alpha1beta1/metabolism, MESH: Neovascularization, Pathologic/drug therapy, MESH: PC12 Cells, MESH: Protein Domains, MESH: Rats, MESH: Viper Venoms/chemistry, MESH: Viper Venoms/metabolism, MESH: Viper Venoms/pharmacology, MESH: Angiogenesis Inhibitors/pharmacology, MESH: Viper Venoms/therapeutic use, MESH: Angiogenesis Inhibitors/therapeutic use, MESH: Animals, MESH: CHO Cells, MESH: Carcinogenesis/drug effects, MESH: Cell Adhesion/drug effects, MESH: Cell Movement/drug effects, MESH: Cell Proliferation/drug effects, [SDV.MHEP.AHA]Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO], Molecular Biology, General Medicine, Biochemistry, Structural Biology, Venom, biology.protein, biology, Peptide, chemistry.chemical_classification, chemistry, Chinese hamster ovary cell, In vitro, Ex vivo, Cell biology

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90e51ea875cbc6ee35aa79287c5c9f3b
https://hal.archives-ouvertes.fr/hal-01873764

4
Phase II study of tivozanib, an oral VEGFR inhibitor, in patients with recurrent glioblastoma

Authors: Kalpathy-Cramer, Jayashree, Chandra, Vyshak, Da, Xiao, Ou, Yangming, Emblem, Kyrre E., Muzikansky, Alona, Cai, Xuezhu, Douw, Linda, Evans, John G., Dietrich, Jorg, Chi, Andrew S., Wen, Patrick Y., Stufflebeam, Stephen, Rosen, Bruce, Duda, Dan G., Jain, Rakesh K., Batchelor, Tracy T., Gerstner, Elizabeth R.

Contributors: Anatomy and neurosciences, Amsterdam Neuroscience - Brain Imaging, Amsterdam Neuroscience - Neuroinfection & -inflammation, CCA - Imaging and biomarkers

Source: Journal of Neuro-Oncology, 131(3), 603-610. Kluwer Academic Publishers
J Neurooncol

Subject Terms: Administration, Oral, Aged, Antineoplastic Agents/therapeutic use, Biomarkers, Tumor/blood, Brain Neoplasms/blood, Female, Glioblastoma/blood, Humans, Male, Middle Aged, Neoplasm Recurrence, Local/diagnostic imaging, Neovascularization, Pathologic/drug therapy, Phenylurea Compounds/therapeutic use, Quinolines/therapeutic use, Receptors, Vascular Endothelial Growth Factor/antagonists & inhibitors, Survival Analysis, Treatment Outcome, Administration, Oral, Biomarkers, Tumor/blood, Neoplasm Recurrence, Local/diagnostic imaging, Neovascularization, Pathologic/drug therapy, Receptors, Vascular Endothelial Growth Factor/antagonists & inhibitors, Cancer Research, Clinical Neurology, Neurology, Oncology, medicine.medical_specialty, medicine, Pathology, Tivozanib, medicine.drug, Progressive disease, medicine.disease, Phases of clinical research, Progression-free survival, business.industry, business, Internal medicine, Angiogenesis, Dynamic contrast-enhanced MRI, Survival analysis, Vascular permeability, Article

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2cf2babf27e1a1162697e555b39bac2
https://research.vumc.nl/en/publications/bd3ebbc0-e5ac-4851-bc2b-7ad6583b5896

5
Targetting αvβ3 and α5β1 integrins with Ecballium elaterium (L.) A. Rich. seed oil

Authors: Imen Touihri-Barakati, Naziha Marrakchi, Belgacem Hanchi, Karim Hosni, Khaoula Khwaldia, Abdennacer Boulila, José Luis, Olfa Kallech-Ziri

Contributors: Laboratoire des Substances Naturelles (LR02INRAP10), Institut National de Recherche et d'Analyse Physico-chimique (INRAP-Tunisie), Faculté de Médecine de Tunis, Université Tunis El Manar (UTM), Laboratoire des Venins et Biomolécules Thérapeutiques - Laboratory of Venoms and Therapeutic Biomolecules (LR11IPT08), Institut Pasteur de Tunis, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP), Faculté des Sciences de Tunis, Université de Tunis [Tunis], Centre de Recherches en Oncologie biologique et Oncopharmacologie (CRO2), Aix Marseille Université (AMU)- Hôpital de la Timone [CHU - APHM] (TIMONE)-Institut National de la Santé et de la Recherche Médicale (INSERM), This research was supported by Ministry of High Education and Scientific Research of Tunisia (MERST) and the Institut National de la Santé et de la Recherche Médicale (INSERM) and by grants from INCa (Institut National du Cancer) and ARCUS (Action en Région de Coopération Universitaire et Scientifique).

Source: Biomedicine and Pharmacotherapy
Biomedicine and Pharmacotherapy, Elsevier Masson, 2016, 84, pp.1223-1232. ⟨10.1016/j.biopha.2016.10.035⟩

Subject Terms: Adhesion, Angiogenesis, Ecballium elaterium, Glioma cell line, Seed oil, αvβ3 and α5β1 integrins, MESH: Brain Neoplasms/blood supply, MESH: Brain Neoplasms/drug therapy, MESH: Glioma/pathology, MESH: Humans, MESH: Integrin alpha5beta1/metabolism, MESH: Integrin beta3/metabolism, MESH: Neovascularization, Pathologic/drug therapy, MESH: Plant Oils/pharmacology, MESH: Plant Oils/therapeutic use, MESH: Seeds/chemistry, MESH: Time-Lapse Imaging, MESH: Brain Neoplasms/pathology, MESH: Cell Adhesion/drug effects, MESH: Cell Line, Tumor, MESH: Cell Movement/drug effects, MESH: Cell Proliferation/drug effects, MESH: Cucurbitaceae/chemistry, MESH: Glioma/blood supply, MESH: Glioma/drug therapy, [SDV]Life Sciences [q-bio], Pharmacology, General Medicine, biology.organism_classification, biology, Cell growth, Cell adhesion, Elaterium, Cell culture, Biochemistry, Fibronectin, biology.protein, Integrin

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::defb1ac9fb0715fda2d704342ce2bc18
https://hal-riip.archives-ouvertes.fr/pasteur-01966126

6
Targetting alphavbeta3 and alpha5beta1 integrins with Ecballium elaterium (L.) A. Rich. seed oil

Authors: Touihri-Barakati, Imen, Kallech-Ziri, Olfa, Boulila, Abdennacer, Khwaldia, Khaoula, Marrakchi, Naziha, Hanchi, Belgacem, Hosni, Karim, Luis, José

Contributors: Laboratoire des Substances Naturelles (LR02INRAP10), Institut National de Recherche et d'Analyse Physico-chimique [Ariana, Tunisie] (INRAP), Laboratoire des Venins et Biomolécules Thérapeutiques - Laboratory of Venoms and Therapeutic Biomolecules (LR11IPT08), Institut Pasteur de Tunis, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP), Faculté de Médecine de Tunis, Université de Tunis El Manar (UTM), Faculté des Sciences Mathématiques, Physiques et Naturelles de Tunis (FST), Centre de Recherches en Oncologie biologique et Oncopharmacologie (CRO2), Aix Marseille Université (AMU)- Hôpital de la Timone [CHU - APHM] (TIMONE)-Institut National de la Santé et de la Recherche Médicale (INSERM), This research was supported by Ministry of High Education and Scientific Research of Tunisia (MERST) and the Institut National de la Santé et de la Recherche Médicale (INSERM) and by grants from INCa (Institut National du Cancer) and ARCUS (Action en Région de Coopération Universitaire et Scientifique).

Source: Biomedicine and Pharmacotherapy
Biomedicine and Pharmacotherapy, Elsevier Masson, 2016, 84, pp.1223-1232. ⟨10.1016/j.biopha.2016.10.035⟩

Subject Terms: Glioma cell line, Angiogenesis, Ecballium elaterium, αvβ3 and α5β1 integrins, Adhesion, Seed oil, MESH: Brain Neoplasms/blood supply, MESH: Brain Neoplasms/drug therapy, MESH: Glioma/drug therapy, MESH: Glioma/pathology, MESH: Humans, MESH: Integrin alpha5beta1/metabolism, MESH: Integrin beta3/metabolism, MESH: Neovascularization, Pathologic/drug therapy, MESH: Plant Oils/pharmacology, MESH: Plant Oils/therapeutic use, MESH: Seeds/chemistry, MESH: Time-Lapse Imaging, MESH: Brain Neoplasms/pathology, MESH: Cell Adhesion/drug effects, MESH: Cell Line, Tumor, MESH: Cell Movement/drug effects, MESH: Cell Proliferation/drug effects, MESH: Cucurbitaceae/chemistry, MESH: Glioma/blood supply, [SDV.CAN]Life Sciences [q-bio]/Cancer, [SDV]Life Sciences [q-bio]

Access URL: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::b2a24ef9fdd79fb4993b858c2f218f07
https://hal-amu.archives-ouvertes.fr/hal-01474971

7
Angiogenesis inhibitors in combinatorial approaches

Authors: Arjan W. Griffioen, Patrycja Nowak-Sliwinska

Contributors: Medical oncology laboratory, CCA - Cancer biology and immunology

Source: Angiogenesis, Vol. 20, No 2 (2017) pp. 183-184
Angiogenesis
Angiogenesis, 20(2), 183-184. Springer Netherlands

Subject Terms: Cancer Research, Clinical Biochemistry, Physiology, Medicine, business.industry, business, MEDLINE, Neovascularization, medicine.symptom, Angiogenesis, Bioinformatics, ddc:615, Angiogenesis Inhibitors/therapeutic use, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Humans, Neoplasms/blood supply/chemistry/drug therapy, Neovascularization, Pathologic/drug therapy

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b216ab396faf20641171d6cdaac5093
http://link.springer.com/article/10.1007/s10456-017-9544-y/fulltext.html

8
Lebein, a snake venom disintegrin, suppresses human colon cancer cells proliferation and tumor-induced angiogenesis through cell cycle arrest, apoptosis induction and inhibition of VEGF expression

Authors: Zohra Aloui, Gilles Pagès, Cezary Marcinkiewicz, Meriam Haoues, Ons Zakraoui, Najet Srairi-Abid, Makram Essafi, Ammar Gasmi, Habib Karoui, Khadija Essafi-Benkhadir, Houcemeddine Othman, Renaud Grépin

Contributors: Laboratoire d'Epidémiologie Moléculaire et de Pathologie Expérimentale Appliquée aux Maladies Infectieuses (LR11IPT04), Université de Tunis El Manar (UTM)-Institut Pasteur de Tunis, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP), Université de Tunis El Manar (UTM), Temple University [Philadelphia], Pennsylvania Commonwealth System of Higher Education (PCSHE), Laboratoire des Venins et Biomolécules Thérapeutiques - Laboratory of Venoms and Therapeutic Biomolecules (LR11IPT08), Institut Pasteur de Tunis, Centre Scientifique de Monaco (CSM), Musée océanographique de Monaco, Laboratoire de Transmission, Contrôle et Immunobiologie des Infections - Laboratory of Transmission, Control and Immunobiology of Infection (LR11IPT02), Institut de Recherche sur le Cancer et le Vieillissement (IRCAN), Université Nice Sophia Antipolis (... - 2019) (UNS), COMUE Université Côte d'Azur (2015 - 2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015 - 2019) (COMUE UCA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Côte d'Azur (UCA), This work was supported by the Tunisian Ministry of Higher Education and Scientific Research, the Institut Pasteur International Network (RIIP) and the University of Nice Sophia Antipolis, the French National Institute of Cancer (INCA) and the French Association for cancer research (ARC).

Source: Molecular Carcinogenesis
Molecular Carcinogenesis, Wiley, 2016, 56, pp.18-35. ⟨10.1002/mc.22470⟩

Subject Terms: colon cancer, disintegrin, tumor growth, cellular effectors, Lebein, MESH: Animals, MESH: Antineoplastic Agents/pharmacology, MESH: Reactive Oxygen Species/metabolism, MESH: Vascular Endothelial Growth Factor A/genetics, MESH: Colon/pathology, MESH: Vascular Endothelial Growth Factor A/metabolism, MESH: Viper Venoms/pharmacology, MESH: Viper Venoms/therapeutic use, MESH: Apoptosis/drug effects, MESH: Cell Cycle Checkpoints/drug effects, MESH: Cell Line, Tumor, MESH: Cell Proliferation/drug effects, MESH: MAP Kinase Signaling System/drug effects, MESH: Chickens, MESH: Colon/drug effects, MESH: Colon/metabolism, MESH: Colonic Neoplasms/drug therapy, MESH: Colonic Neoplasms/genetics, MESH: Colonic Neoplasms/metabolism, MESH: Colonic Neoplasms/pathology, MESH: Down-Regulation/drug effects, MESH: Humans, MESH: Integrin beta1/metabolism, MESH: Mice, Nude, MESH: Antineoplastic Agents/therapeutic use, MESH: Models, Molecular, MESH: Neovascularization, Pathologic/drug therapy, MESH: Neovascularization, Pathologic/genetics, MESH: Neovascularization, Pathologic/metabolism, MESH: Neovascularization, Pathologic/pathology, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology, [SDV.CAN]Life Sciences [q-bio]/Cancer, [SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology, Cancer Research, Molecular Biology, Programmed cell death, Cell cycle, Angiogenesis, Vascular endothelial growth factor A, Cell growth, Biology, Neuropilin 1, Cell biology, Vascular endothelial growth factor, chemistry.chemical_compound, chemistry, Apoptosis

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0585f28438d7476124d0d6c1804ac8fb
https://hal.archives-ouvertes.fr/hal-01356511

9
Neutralization of Tumor Necrosis Factor Bioactivity Ameliorates Urethane-Induced Pulmonary Oncogenesis in Mice

Authors: Sophia Magkouta, Chrysoula A. Kairi, Charis Roussos, Spyros Zakynthinos, Ioannis Psallidas, Georgios T. Stathopoulos, Sophia P. Karabela, Ioannis Kalomenidis, Charalampos Moschos, Ioannis P. Stathopoulos

Source: Europe PubMed Central
Neoplasia: An International Journal for Oncology Research, Vol 13, Iss 12, Pp 1143-1151 (2011)
Neoplasia (New York, N.Y.) 13(12) 1143-1151 (2011)

Subject Terms: Cancer Research, Tumor necrosis factor alpha, Internal medicine, medicine.medical_specialty, medicine, Lewis lung carcinoma, Tumor initiation, Interleukin 10, Cancer research, Interferon, medicine.drug, Tumor progression, Endocrinology, Etanercept, Interleukin, business.industry, business, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, lcsh:RC254-282, Animals, Carcinogens/administration & dosage, Cell Line, Tumor, Cell Proliferation/drug effects, Cell Transformation, Neoplastic/drug effects, Immunoglobulin G/administration & dosage, Immunoglobulin G/pharmacology, Immunologic Factors/administration & dosage, Immunologic Factors/pharmacology, Interferon-gamma/biosynthesis, Interleukin-10/biosynthesis, Lung Neoplasms/chemically induced, Lung Neoplasms/drug therapy, Lung Neoplasms/metabolism, Lung/drug effects, Lung/metabolism, Lung/pathology, Macrophages/drug effects, Macrophages/metabolism, Mice, Mice, Inbred BALB C, Neovascularization, Pathologic/drug therapy, Pneumonia/chemically induced, Pneumonia/drug therapy, Receptors, Tumor Necrosis Factor/administration & dosage, Receptors, Tumor Necrosis Factor/metabolism, Signal Transduction/drug effects, Tumor Necrosis Factor-alpha/antagonists & inhibitors, Tumor Necrosis Factor-alpha/metabolism, Urethane/administration & dosage

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75ecb36ac6f277e78212b02aeb076b40

10
Video monitoring of neovessel occlusion induced by photodynamic therapy with verteporfin (Visudyne®), in the CAM model

Authors: Debefve, E., Pegaz, B., van den Bergh, H., Wagnières, G., Lange, N., Ballini, J.-P.

Source: Angiogenesis
Angiogenesis, Vol. 11, No 3 (2008) pp. 235-43

Subject Terms: Original Paper, Choroid, Neovascularization, Photodynamic therapy, Vascular occlusion, Chorioallantoic membrane, CAM model, Verteporfin, Visudyne®, Animals, Chick Embryo, Disease Models, Animal, Gamma Cameras/standards, Laser Coagulation/methods, Models, Biological, Neovascularization, Pathologic/drug therapy/surgery, Photochemotherapy/instrumentation/methods, Photosensitizing Agents/therapeutic use, Porphyrins/therapeutic use, Time Factors, Treatment Outcome, Video-Assisted Surgery/instrumentation/methods, Clinical Biochemistry, Cancer Research, Physiology, Extravasation, medicine.symptom, medicine, Occlusion, medicine.drug, Biomedical engineering, Surgery, medicine.medical_specialty, medicine.medical_treatment, Thrombus, medicine.disease, business.industry, business, Macular degeneration

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5a783f2f47c301fe6dc730d0fcecc24
http://europepmc.org/articles/PMC2494573

11
Recombinant human erythropoietin α modulates the effects of radiotherapy on colorectal cancer microvessels

Authors: Pieter Demetter, Peter Smeets, N. Van Damme, O Zwaenepoel, Tom Boterberg, L Cesteleyn, Piet Pattyn, Marc Peeters, Philippe Houtmeyers, Wim Ceelen

Source: British Journal of Cancer
British Journal of Cancer, 96 (5

Subject Terms: Cancer Research, Oncology, Vascular endothelial growth factor, chemistry.chemical_compound, chemistry, Tumor hypoxia, Medicine, business.industry, business, Cancer, medicine.disease, Cancer research, Erythropoietin, medicine.drug, Pathology, medicine.medical_specialty, Endothelium, medicine.anatomical_structure, Microvessel, Receptor expression, Microcirculation, Clinical Studies, erythropoietin, radiothkerapy, oxygenation, colorectal, microcirculation, Anatomopathologie, Médecine pathologie humaine, Adenocarcinoma -- blood supply -- drug therapy -- radiotherapy, Animals, Colorectal Neoplasms -- blood supply -- drug therapy -- radiotherapy, Erythropoietin -- pharmacology, Humans, Magnetic Resonance Imaging, Male, Models, Biological, Neovascularization, Pathologic -- drug therapy -- radiotherapy, Rats, Receptors, Erythropoietin -- metabolism, Recombinant Proteins, Colorectal, Oxygenation, Radiothkerapy

File Description: 1 full-text file(s): application/pdf

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d6efa9af05b48257dc0bf8ef36704a5
http://www.nature.com/articles/6603568.pdf

PDF Full Text
12
Anti-angiogenesis therapy can overcome endothelial cell anergy and promote leukocyte-endothelium interactions and infiltration in tumors

Authors: Dirkx, Anita E. M., Egbrink, Mirjam G. A. oude, Castermans, Karolien, Schaft, Daisy W. J., Thijssen, Victor L. J. L., Dings, Ruud P. M., Kwee, Lucy, Mayo, Kevin H., Wagstaff, John, Steege, Jessica C. A. Bouma‐ter, Griffioen, Arjan W.

Contributors: Soft Tissue Biomech. & Tissue Eng., Medical oncology laboratory, Radiation Oncology, CCA - Cancer biology and immunology, CCA - Imaging and biomarkers, CCA - Treatment and quality of life

Source: The FASEB Journal, 20(6), 621-630. FASEB
FASEB Journal, 20(6), 621-30. FASEB

Subject Terms: Angiostatins/pharmacology, Animals, Antineoplastic Agents/pharmacology, Cell Line, Tumor, Clonal Anergy, Cyclohexanes, Cyclophosphamide/pharmacology, Down-Regulation, Endostatins/pharmacology, Endothelial Cells, Endothelium/cytology, Humans, Intercellular Adhesion Molecule-1/metabolism, Leukocytes/cytology, Mice, Neoplasms/blood supply, Neovascularization, Pathologic/drug therapy, Paclitaxel/pharmacology, Proteins/pharmacology, Sesquiterpenes/pharmacology, Tumor Necrosis Factor-alpha, Vascular Cell Adhesion Molecule-1/metabolism, SDG 3 - Good Health and Well-being, Cell Line, Tumor, Neovascularization, Pathologic/drug therapy, Genetics, Molecular Biology, Biochemistry, Biotechnology, Ex vivo, Cell adhesion molecule, Angiostatin, Clonal anergy, Endostatin, Cell biology, Angiogenesis, Tumor Escape, Endothelial stem cell, Biology

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::498f4b92f9f125e8482eeae086b95717

13
Eur(omega)conference Angiogenesis II

Authors: van Beijnum, Judy R, Fan, Tai-Ping D, Griffioen, Arjan W

Contributors: Medical oncology laboratory, CCA - Cancer biology and immunology, CCA - Imaging and biomarkers, CCA - Treatment and quality of life

Source: Angiogenesis, 6(3), 159-64. Springer Netherlands

Subject Terms: Angiogenesis Inhibitors/chemistry, Endothelial Cells/metabolism, Europe, Gene Expression Profiling, Growth Substances, Humans, Neoplasms/pathology, Neovascularization, Pathologic/drug therapy, Research, Neovascularization, Pathologic/drug therapy

Access URL: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::b105a5fd1e21f1a0e2173efbf80c5e40

14
Angiogenesis in neurological disorders: A review

Authors: Ramazan Demir, Göksemin Acar, Gamze Tanriover

Subject Terms: Angiogenesis, Anti-angiogenic therapies, Neurological disorders, Tumor metastasis, angiogenesis inhibitor, angiotensin II, bevacizumab, camptothecin, cediranib, cyclophosphamide, erlotinib, gefitinib, gelatinase A, gelatinase B, imatinib, lomustine, nevaxar, scatter factor, sorafenib, thrombospondin 1, unclassified drug, vasculotropin, vatalanib, antiangiogenic activity, arteriovenous malformation, blood brain barrier, brain blood vessel, brain disease, brain metastasis, cancer chemotherapy, cancer growth, cancer prognosis, cell proliferation, competitive inhibition, down regulation, drug efficacy, glioblastoma, hemangioblastoma, hereditary hemorrhagic telengiectasia, histopathology, human, hypertension, hypoxemia, macrophage, maximum tolerated dose, meningioma, neurologic disease, overall survival, progression free survival, protein expression, protein secretion, review, signal transduction, thrombocytopenia, tumor cell, tumor localization, tumor vascularization, upregulation, vascular tumor, Angiogenesis Inhibitors, Animals, Brain Neoplasms, Humans, Neovascularization, Pathologic, Nervous System Diseases, Tumor, metastasis, Angiogenesis Inhibitors/therapeutic use, Brain Neoplasms/drug therapy/metabolism/pathology, Neovascularization, Pathologic/drug therapy/*metabolism/*pathology, Nervous System Diseases/drug therapy/*metabolism/*pathology, Clinical Neurology, Neurology, General Medicine, Potential impact, Pathology, medicine.medical_specialty, medicine, Cancer research, Malignancy, medicine.disease, Metastasis, Tumor cells, business.industry, business, Tumor growth, Primary tumor, Cancer therapy

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fa9f5bfd39a19299ce7d6b9c41bff93
http://acikerisim.pau.edu.tr:8080/xmlui/handle/11499/8491

15
Targeting Vascular NADPH Oxidase 1 Blocks Tumor Angiogenesis through a PPARα Mediated Mechanism

Authors: Garrido-Urbani Sarah, Jemelin Stephane, Deffert Christine, Carnesecchi Stéphanie, Basset Olivier, Szyndralewiez Cédric, Heitz Freddy, Page Patrick, Montet Xavier, Michalik Liliane, Arbiser Jack, Rüegg Curzio, Krause Karl Heinz, Imhof Beat A, Imhof Beat

Source: PLoS ONE
PloS one
PLOS ONE, Vol. 6, No 2 (2011) P. e14665
PLoS ONE, Vol 6, Iss 2, p e14665 (2011)

Subject Terms: Research Article, Cell Biology, Oncology, Cardiovascular Disorders/Vascular Biology, ddc:616.07, ddc:612, Angiogenesis Inhibitors/pharmacology/therapeutic use, Animals, Cells, Cultured, Endothelial Cells/drug effects/metabolism, Female, Gene Knockdown Techniques, Gene Targeting, Humans, Mice, Mice, Inbred C57BL, Mice, Knockout, Models, Biological, Molecular Targeted Therapy, NADH, NADPH Oxidoreductases/antagonists & inhibitors/genetics/physiology, Neoplasms/blood supply/drug therapy/genetics, Neovascularization, Pathologic/drug therapy/genetics, PPAR alpha/genetics/physiology, Pyrazoles/pharmacology/therapeutic use, Pyridones/pharmacology/therapeutic use, RNA, Small Interfering/pharmacology, Signal Transduction/drug effects/genetics, lcsh:Medicine, lcsh:R, lcsh:Science, lcsh:Q, Multidisciplinary, Signal transduction, NOX4, Neovascularization, medicine.symptom, medicine, Molecular biology, Angiogenesis, NADPH Oxidase 1, Cell biology, Cell migration, Biology, NOX1, Endothelial stem cell, cardiovascular system

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::138bc571224003ab788ac97181f2419c
http://europepmc.org/articles/PMC3034713

PDF Full Text
16
Targeting vascular NADPH oxidase 1 blocks tumor angiogenesis through a PPARα mediated mechanism

Authors: Garrido-Urbani, S., Jemelin, S., Deffert, C., Carnesecchi, S., Basset, O., Szyndralewiez, C., Heitz, F., Page, P., Montet, X., Michalik, L., Arbiser, J., Rüegg, C., Krause, K.H., Imhof, B.A., Imhof, B.

Source: PloS One, vol. 6, no. 2, pp. e14665

Subject Terms: Angiogenesis Inhibitors/pharmacology, Angiogenesis Inhibitors/therapeutic use, Animals, Cells, Cultured, Endothelial Cells/drug effects, Endothelial Cells/metabolism, Female, Gene Knockdown Techniques, Gene Targeting, Humans, Mice, Mice, Inbred C57BL, Mice, Knockout, Models, Biological, Molecular Targeted Therapy, NADH, NADPH Oxidoreductases/antagonists & inhibitors, NADH, NADPH Oxidoreductases/genetics, Neoplasms/blood supply, Neoplasms/drug therapy, Neovascularization, Pathologic/drug therapy, Neovascularization, Pathologic/genetics, PPAR alpha/genetics, PPAR alpha/physiology, Pyrazoles/pharmacology, Pyrazoles/therapeutic use, Pyridones/pharmacology, Pyridones/therapeutic use, RNA, Small Interfering/pharmacology, Signal Transduction/drug effects, Signal Transduction/genetics, cardiovascular system

File Description: application/pdf

Access URL: https://explore.openaire.eu/search/publication?articleId=od______1900::7fb0e7c92e2080d5b1c131e8cc003649
https://serval.unil.ch/resource/serval:BIB_E36D61042E0B.P001/REF.pdf

18
Angiostatic activity of the antitumor cytokine interleukin-21

Authors: Protul Shrikant, Warren J. Leonard, Arjan W. Griffioen, Judy R. van Beijnum, Sébastien Tabruyn, Cheryl Eppolito, Karolien Castermans, Rong Zeng

Contributors: Medical oncology laboratory, CCA - Cancer biology and immunology, CCA - Imaging and biomarkers, CCA - Treatment and quality of life

Source: Blood, 112(13), 4940-7. American Society of Hematology

Subject Terms: Angiogenesis Inhibitors/pharmacology, Animals, Antineoplastic Agents, Aorta/cytology, Cell Line, Cell Line, Tumor, Cell Proliferation/drug effects, Chick Embryo, Endothelial Cells/cytology, Endothelium, Vascular/cytology, Humans, Interleukins/pharmacology, Mice, Neovascularization, Pathologic/drug therapy, Neovascularization, Physiologic/drug effects, Phosphorylation/drug effects, Receptors, Interleukin-21, STAT3 Transcription Factor/metabolism, Tumor, Endothelium, Vascular/cytology, Neovascularization, Pathologic/drug therapy, Physiologic/drug effects, Receptors, Interleukin-21, Cell Biology, Hematology, Immunology, Biochemistry, Chorioallantoic membrane, Angiogenesis, Cytokine, medicine.medical_treatment, medicine, Immunotherapy, Cancer research, In vivo, Interleukin 21, Biology, Endothelial stem cell, medicine.symptom, Hemostasis, Thrombosis, and Vascular Biology

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::660b7e5275cf22d6fd4d734fb605f1e1
https://research.vumc.nl/en/publications/19475a79-aaf9-4ef8-a4dd-286de3829113

19
Antiangiogenesis therapy for endometriosis

Authors: Patrick G. Groothuis, Johannes L.H. Evers, Arjan W. Griffioen, Jessica C.A. Bouma-ter Steege, Gerard A.J. Dunselman, Annemiek W. Nap, Victor L. Thijssen

Contributors: Medical oncology laboratory, CCA - Cancer biology and immunology, CCA - Imaging and biomarkers, CCA - Treatment and quality of life, Radiation Oncology, Rijksuniversiteit Groningen

Source: The Journal of clinical endocrinology and metabolism, 89(3), 1089-95. The Endocrine Society
Journal of Clinical Endocrinology and Metabolism, 89(3), 1089-1095. ENDOCRINE SOC

Subject Terms: Adult, Angiogenesis Inhibitors/pharmacology, Animals, Cyclohexanes, Endometriosis/drug therapy, Endometrium/blood supply, Endostatins/pharmacology, Female, Humans, Mice, Mice, Nude, Neovascularization, Pathologic/drug therapy, Proteins/pharmacology, Sesquiterpenes/pharmacology, Nude, Neovascularization, Pathologic/drug therapy, Biochemistry, medical, Clinical Biochemistry, Endocrinology, Biochemistry, Endocrinology, Diabetes and Metabolism, Antiangiogenesis Therapy, Vascular endothelial growth factor A, medicine.symptom, medicine, Endometrium, medicine.anatomical_structure, Internal medicine, medicine.medical_specialty, Endostatin, Vascular endothelial growth factor, chemistry.chemical_compound, chemistry, Endometriosis, medicine.disease, Angiogenesis, business.industry, business

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3be7160bc7e29a1313f9c8d03ed2e525
https://research.vumc.nl/en/publications/d4a82866-b63d-4290-8308-2f87b9b4301c

20
Cyclooxygenase-2 in human and experimental ischemic proliferative retinopathy

Authors: Florian Sennlaub, Alejandro Vazquez-Tello, Fatemeh Valamanesh, Martin Beauchamp, Bupe R. Mwaikambo, Karel Geboes, Francine Behar-Cohen, Yves Courtois, Daniella Checchin, Huy Ong, Fernand Gobeil, Ahmed M. Abu El-Asrar, Sonia Brault, Sylvain Chemtob, Daya R. Varma, Pierre Lachapelle

Contributors: Développement, vieillissement et pathologie de la rétine, Institut National de la Santé et de la Recherche Médicale (INSERM), Departments of Pediatrics, Ophthalmology, and Pharmacology, Research Center of Hôpital Sainte-Justine, Departments of Pharmacology, McGill University = Université McGill [Montréal, Canada], Departments of Ophtalmology, Faculty of Pharmacy [Montréal, QC, Canada], Université de Montréal (UdeM)

Source: Circulation
Circulation, American Heart Association, 2003, 108 (2), pp.198-204. ⟨10.1161/01.CIR.0000080735.93327.00⟩
Europe PubMed Central
Circulation, vol. 108, no. 2, pp. 198-204

Subject Terms: MESH: Adult, MESH: Aged, MESH: Disease Models, Animal, MESH: Endothelial Growth Factors, MESH: Enzyme Inhibitors, MESH: Female, MESH: Humans, MESH: Intercellular Signaling Peptides, MESH: Animals, MESH: Antigens, CD36, MESH: Astrocytes, MESH: Cell Division, MESH: Cells, Cultured, MESH: Cyclooxygenase 2, MESH: Diabetic Retinopathy, MESH: Dinoprostone, [SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC], Adult, Aged, Animals, Antigens, CD36/metabolism, Astrocytes/drug effects, Astrocytes/enzymology, Cell Division/drug effects, Cells, Cultured, Cyclooxygenase 2, Diabetic Retinopathy/complications, Diabetic Retinopathy/drug therapy, Dinoprostone/metabolism, Disease Models, Animal, Endothelial Growth Factors/metabolism, Enzyme Inhibitors/pharmacology, Female, Humans, Intercellular Signaling Peptides and Proteins/metabolism, Ischemia/complications, Ischemia/enzymology, Isoenzymes/antagonists & inhibitors, Isoenzymes/metabolism, Lymphokines/metabolism, Male, Membrane Proteins, Mice, Mice, Inbred C57BL, Middle Aged, Neovascularization, Pathologic/drug therapy, Neovascularization, Pathologic/pathology, Prostaglandin-Endoperoxide Synthases/metabolism, Rats, Rats, Sprague-Dawley, Receptors, Immunologic, Receptors, Lipoprotein/metabolism, Receptors, Prostaglandin E/drug effects, Receptors, Prostaglandin E/metabolism, Receptors, Prostaglandin E, EP3 Subtype, Receptors, Prostaglandin E, EP4 Subtype, Receptors, Scavenger, Retina/drug effects, Retina/enzymology, Retinal Vessels/drug effects, Retinal Vessels/pathology, Thrombospondin 1/metabolism, Vascular Endothelial Growth Factor A, Vascular Endothelial Growth Factor Receptor-2/metabolism, Vascular Endothelial Growth Factors, Vitreoretinopathy, Proliferative/complications, Vitreoretinopathy, Proliferative/drug therapy, Physiology (medical), Cardiology and Cardiovascular Medicine, Neovascularization, medicine.symptom, medicine, Ischemia, medicine.disease, Prostaglandin E, medicine.medical_treatment, Internal medicine, medicine.medical_specialty, Cancer research, business.industry, business, Prostaglandin E2, medicine.drug, Endocrinology, Cyclooxygenase, biology.protein, biology, Diabetic retinopathy, Vascular endothelial growth factor A, Retinopathy, genetic structures

File Description: application/pdf

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07c63462fb4e0ebba326cc15f1437dda
https://www.hal.inserm.fr/inserm-00150824

Search Tools: Get RSS Feed — Email this Search